Abstract:OBJECTIVE:To investigate the significance of genomic amplification of the telomerase RNA component (TERC) gene to serve as a genetic biomarker in the screening of cervical lesions. METHODS:A total of 715 cases were recruited, with liquid-based cytology diagnosis as normal (n = 347), atypical squamous cells of undetermined significance (ASCUS, n = 180), atypical squamous cells cannot exclude a high-grade lesion (ASC-H, n = 13), low-grade squamous intraepithelial lesions (LSIL, n = 115), high-grade squamous intraepithelial lesions (HSIL, n = 59) and atypical glandular cells (AGC, n = 1). The remaining cervical cells in the cytological preserving fluid were analyzed using a two-color fluorescence in situ hybridization (FISH) probe targeted to chromosome 3q26 containing TERC gene. The TERC gene findings were compared to the cytological and histological detected results, as well as high-risk human papillomavirus (HPV) detected results. RESULTS:Genomic amplification of TERC gene was found in 5.8% of normal specimens, 22.2% of ASCUS, 30.8% of ASC-H, 27.8% of LSIL, 86.4% of HSIL and 1/1 of AGC. The positive rate was significantly lower in normal, ASCUS, ASC-H and LSIL compared with HSIL (all P < 0.01). Significantly more cells with genomic amplification of TERC gene were found in cervical intraepithelial lesion (CIN) II-III than CINI (77.8% vs. 9.3%), as well as invasive cervical cancer (96.7% vs. 9.3%), both P < 0.01. The rate of TERC gene amplification was higher in HPV positive patients (33.5%) than in HPV negative patients (5.2%, P < 0.01). The sensitivity of TERC gene amplification was significantly higher than that of cytological screening (81.88% vs. 36.96%, P < 0.01) in the differentiation of CINII or higher and CINI or lower diseases, its specificity was higher than high-risk HPV test (93.32% vs. 33.93%, P < 0.01) and positive prediction value (81.29%) was similar with cytological method (86.44%, P > 0.05); but its negative prediction value (93.56%) was lower than HPV test (97.06%, P < 0.05). CONCLUSIONS:The positive rates of TERC gene amplification increased as cervical diseases worsened. TERC gene amplification is related to HPV infection. The gain of chromosome 3q26 in cytological specimens is an effective molecular genetic biomarker in screening of CINII or higher and invasive cervical cancer.

Telomerase RNA Gene (TERC) and Recent Studies on Cervical Cancer

Detection of TERC Amplification in Cervical Epithelial Cells for the Diagnosis of High-Grade Cervical Lesions and Invasive Cancer: A Multicenter Study in China

[Clinical Application of Telomerase RNA Component Gene Amplification Assay in Cervical Lesions.].

Expression of the human telomerase gene in cytologic specimens of cervix

[Evaluation of Genomic Amplification of the Human Telomerase RNA Component Gene in the Screening of Cervical Lesions].

Human Telomerase Rna Gene Amplification Detection Increases the Specificity of Cervical Intraepithelial Neoplasia Screening

Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders.

Application of Hterc in Thinprep Samples with Mild Cytologic Abnormality and HR-HPV Positive

Detection Of Human Telomerase Rna Gene In Cervical Cancer And Precancerous Lesions Comparison With Cytological And Human Papillomavirus Dna Test Findings

Different Amplification Patterns of the Human Telomerase RNA Gene in Invasive Cervical Carcinomas and Cervical Intraepithelial Neoplasia Grade III

METTL3 Regulates the Malignancy of Cervical Cancer Via Post-Transcriptional Regulation of RAB2B

Expression and significance of TERC gene in cervical tumor

Expression and clinical significance of telomerase gene and C-myc gene in cervical intraepithelial neoplasia

Detection and Clinical Significance of TERC Amplification in Different Cervical Lesions

Amplification of the Telomerase RNA Component Gene As a New Genetic Marker for Disease Progression and Prognosis in Esophageal Squamous Cell Carcinoma.

Expression and Significance of Hterc Gene by FISH Detection in Cervical Lesions

Study on TERC Gene Change in Cervical Cells by Fluorescence in Situ Hybridization in Women with CIN

The Application of Hterc Gene Amplification in Diagnosis and Treatment of Cervical Lesions

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Telomerase RNA and Telomerase Activity in Trophoblastic Tumors

Telomerase mutations and carcinogenesis